AEON — AEON BIOPHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.09 | — | -0.08 | -0.09 | 2 | — |
| Mar 2027 | -0.09 | — | -0.09 | -0.09 | 1 | — |
| Jun 2027 | -0.06 | — | -0.06 | -0.06 | 1 | — |
| Sep 2027 | -0.05 | — | -0.05 | -0.05 | 1 | — |
| Dec 2027 | -0.06 | — | -0.06 | -0.06 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.55 | — | -0.53 | -0.56 | 2 | — |
| Dec 2027 | -0.23 | — | -0.22 | -0.25 | 2 | — |
| Dec 2028 | -0.11 | — | -0.11 | -0.11 | 1 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 25 SEC-registered investment managers reported holding AEON (AEON BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $18.71M across 62.26M shares. That is +308.9% by share count (+39.45M shares) versus the previous quarter, while reported value moved +68.9%. Ownership is concentrated: the five largest holders account for 97.9% of reported value and the top ten for 99.5%.
Compared with the prior quarter, 10 opened new positions, 3 added to existing stakes, 8 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of AEON BIOPHARMA INC (AEON) include Shaolin Capital Management LLC, KIM, LLC, Dauntless Investment Group, LLC, ranked by reported 13F value among the 70 institutional holders on this page.
AEON is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 25 | 62.26M | $18.71M | +308.9% |
| Q2 2026 | 23 | 12.90M | $9.41M | +355.8% |
| Q1 2026 | 24 | 2.84M | $2.80M | +16.8% |
| Q4 2025 | 21 | 2.44M | $1.67M | +79.8% |
| Q3 2025 | 20 | 1.36M | $1.10M | -0.3% |
| Q2 2025 | 17 | 1.27M | $585.71K | +11.9% |
| Q1 2025 | 15 | 1.53M | $884.77K | -98.5% |
| Q4 2024 | 36 | 8.88M | $4.80M | -8.6% |
Over the 8 quarters shown, institutional share counts increased 601% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+355.8%).
Top Institutional Holders (Q3 2026) — 25 funds
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 23 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 12.49M | $8.98M | 7.06% | Add | |
| 170 | $122.00K | 0.01% | Hold | |
| 95.31K | $68.56K | 0.00% | New | |
| 95.31K | $68.56K | 0.00% | Add | |
| 90.53K | $65.09K | 0.00% | Hold | |
| 42.35K | $30.49K | 0.01% | Hold | |
| 20.02K | $19.72K | 0.00% | Hold | |
| 18.95K | $14.94K | 0.00% | New | |
| 13.71K | $9.86K | 0.00% | Reduce | |
| 11.51K | $8.28K | 0.00% | Hold | |
| 7.32K | $5.26K | 0.00% | Add | |
| 5.06K | $3.64K | 0.00% | Add | |
| 2.83K | $2.04K | 0.00% | Hold | |
| 2.57K | $1.85K | 0.00% | Add | |
| 1.10K | $791 | 0.00% | Hold | |
| 567 | $408 | 0.00% | Hold | |
| 232 | $167 | 0.00% | Add | |
| 150 | $108 | 0.00% | Hold | |
| 95 | $69 | 0.00% | Hold | |
| 90 | $65 | 0.00% | Hold | |
| 59 | $42 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold | |
| 1 | $1 | 0.00% | Hold |
Q1 2026 — 24 funds
Q4 2025 — 21 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.13M | $1.32M | 1.05% | Add | |
| 100.33K | $110.37K | 0.00% | Add | |
| 60.13K | $66.15K | 0.00% | Add | |
| 56.85K | $62.54K | 0.00% | Add | |
| 43.40K | $47.73K | 0.01% | Add | |
| 15.00K | $16.50K | 0.00% | New | |
| 13.18K | $14.50K | 0.00% | New | |
| 11.64K | $12.81K | 0.00% | New | |
| 4.05K | $4.46K | 0.00% | Add | |
| 2.83K | $3.12K | 0.00% | Hold | |
| 2.38K | $2.62K | 0.00% | Hold | |
| 567 | $624 | 0.00% | Add | |
| 170 | $187 | 0.00% | Hold | |
| 150 | $165 | 0.00% | Hold | |
| 105 | $116 | 0.00% | Reduce | |
| 100 | $110 | 0.00% | Hold | |
| 95 | $105 | 0.00% | Hold | |
| 90 | $99 | 0.00% | Hold | |
| 58 | $64 | 0.00% | Hold | |
| 4 | $4 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q3 2025 — 20 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.12M | $909.67K | 0.57% | Hold | |
| 98.57K | $79.74K | 0.00% | New | |
| 47.07K | $38.06K | 0.00% | Add | |
| 42.35K | $34.25K | 0.01% | Hold | |
| 17.58K | $14.21K | 0.00% | New | |
| 16.16K | $13.07K | 0.00% | New | |
| 10.42K | $8.43K | 0.00% | New | |
| 2.83K | $2.29K | 0.00% | Reduce | |
| 2.38K | $1.92K | 0.00% | Hold | |
| 1.19K | $964 | 0.00% | Reduce | |
| 170 | $137 | 0.00% | Hold | |
| 150 | $121 | 0.00% | Hold | |
| 106 | $86 | 0.00% | Hold | |
| 100 | $81 | 0.00% | Hold | |
| 95 | $77 | 0.00% | Add | |
| 90 | $73 | 0.00% | Hold | |
| 67 | $55 | 0.00% | Hold | |
| 58 | $47 | 0.00% | Hold | |
| 21 | $17 | 0.00% | New | |
| 1 | $1 | 0.00% | Hold |
Q2 2025 — 17 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.12M | $475.00K | 0.83% | Add | |
| 45.26K | $34.00K | 0.00% | New | |
| 42.35K | $32.19K | 0.01% | Hold | |
| 31.60K | $24.02K | 0.00% | Add | |
| 20.70K | $15.73K | 0.00% | New | |
| 2.85K | $2.17K | 0.00% | Reduce | |
| 2.38K | $1.81K | 0.00% | Add | |
| 272 | $207 | 0.00% | New | |
| 170 | $129 | 0.00% | Hold | |
| 150 | $114 | 0.00% | Hold | |
| 106 | $81 | 0.00% | Hold | |
| 100 | $76 | 0.00% | Hold | |
| 90 | $68 | 0.00% | Hold | |
| 67 | $51 | 0.00% | Hold | |
| 58 | $45 | 0.00% | Hold | |
| 24 | $19 | 0.00% | Add | |
| 1 | $1 | 0.00% | Hold |
New Positions (Q3 2026)
- Nantahala Capital Management, LLC 4.40M sh · $1.30M
- Ikarian Capital, LLC 2.20M sh · $661.02K
- Stonepine Capital Management, LLC 2.13M sh · $637.72K
- BOOTHBAY FUND MANAGEMENT, LLC 703.87K sh · $211.16K
- DG Capital Management, LLC 259.15K sh · $77.74K
- JANE STREET GROUP, LLC 249.76K sh · $74.93K
- Citadel Advisors 55.68K sh · $16.70K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 21.02K sh · $6.30K
- Beacon Wealthcare LLC 12.86K sh · $3.86K
- XTX Topco Ltd 11.01K sh · $3.30K
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 95.31K sh · $68.56K
- StoneX Group Inc. sold 18.95K sh · $14.94K
- Citigroup Inc sold 7.32K sh · $5.26K
- UBS Group AG sold 5.06K sh · $3.64K
- Tower Research Capital LLC (TRC) sold 2.57K sh · $1.85K
- BARCLAYS PLC sold 59 sh · $42
- Caitong International Asset Management Co., Ltd sold 1 sh · $1
- DANSKE BANK A/S sold 1 sh · $1
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dauntless Investment Group, LLC | 51.73M | 12.49M | 2.53M | 2.13M | 1.12M | 1.12M | 1.02M | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 4.40M | — | — | — | — | — | — | — | — | — | — | — | — |
| Ikarian Capital, LLC | 2.20M | — | — | — | — | — | — | 257.56K | 257.98K | 257.98K | 257.98K | 257.98K | 257.98K |
| Stonepine Capital Management, LLC | 2.13M | — | — | — | — | — | — | — | — | — | — | — | — |
| BOOTHBAY FUND MANAGEMENT, LLC | 703.87K | — | — | — | — | — | — | 54.65K | 55.06K | 55.06K | 55.06K | 55.06K | 55.06K |
| DG Capital Management, LLC | 259.15K | — | — | — | — | — | — | — | — | — | — | — | — |
| JANE STREET GROUP, LLC | 249.76K | — | 16.38K | — | 10.42K | — | — | 11.01K | 10.71K | 23.27K | 36.25K | — | — |
| VANGUARD FIDUCIARY TRUST CO | 214.72K | 13.71K | 14.70K | — | — | — | — | — | — | — | — | — | — |
| DUPONT CAPITAL MANAGEMENT CORP | 170 | 170 | 170 | 170 | 170 | 170 | 170 | 12.28K | 12.28K | 12.28K | 3 | 3 | 3 |
| Geode Capital Management | 95.31K | 95.31K | 87.06K | 60.13K | 47.07K | 20.70K | — | 251.78K | 243.17K | 186.86K | 179.59K | 172.25K | 171.35K |
| VANGUARD CAPITAL MANAGEMENT LLC | 90.53K | 90.53K | 90.53K | — | — | — | — | — | — | — | — | — | — |
| Citadel Advisors | 55.68K | — | — | 11.64K | — | — | — | — | — | — | — | — | 10.61K |
| Formidable Asset Management, LLC | 20.02K | 20.02K | 20.02K | — | — | — | — | 689.18K | 389.78K | 113.64K | 68.19K | 58.19K | 64.31K |
| Blue Owl Capital Holdings LP | 42.35K | 42.35K | 42.35K | 43.40K | 42.35K | 42.35K | 42.35K | 3.05M | 3.34M | — | — | — | — |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 21.02K | — | — | — | — | — | — | — | — | — | — | — | — |
| Beacon Wealthcare LLC | 12.86K | — | — | — | — | — | — | — | — | — | — | — | — |
| LPL Financial LLC | 11.50K | 11.51K | 11.51K | — | — | — | — | 37.81K | 26.84K | — | — | — | — |
| XTX Topco Ltd | 11.01K | — | 20.42K | 56.85K | 16.16K | — | — | — | — | — | — | — | — |
| BlackRock Inc | 2.83K | 2.83K | 2.83K | 2.83K | 2.83K | 2.85K | 3.67K | 265.52K | 265.15K | — | — | — | — |
| Steward Partners Investment Advisory, LLC | 1.10K | 1.10K | 1.10K | 100 | 100 | 100 | 100 | 8.20K | 7.20K | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold AEON?
As of 2026-Q3, 25 institutional funds reported holding AEON (AEON BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $18.71M.
How many shares of AEON do institutions own?
13F filers reported 62.26M shares of AEON, worth $18.71M in aggregate at the end of 2026-Q3.
Is institutional ownership of AEON rising or falling?
Share counts moved +308.9% versus the prior quarter — accumulation.
Who are the top institutional holders of AEON?
The largest 13F holders are Shaolin Capital Management LLC, KIM, LLC, Dauntless Investment Group, LLC, Polar Asset Management Partners Inc., Nantahala Capital Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AEON BIOPHARMA INC?
The major shareholders of AEON BIOPHARMA INC (AEON) by reported 13F value are Shaolin Capital Management LLC, KIM, LLC, Dauntless Investment Group, LLC, Polar Asset Management Partners Inc., Nantahala Capital Management, LLC, among 70 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.